Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.verified

XENE

Price:

$44.61

Market Cap:

$3.45B

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopa...[Read more]

Industry

Biotechnology

IPO Date

2014-11-05

Stock Exchange

NASDAQ

Ticker

XENE

The PE Ratio as of December 2025 (TTM) for Xenon Pharmaceuticals Inc. (XENE) is -11.47

According to Xenon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.47. This represents a change of 10.95% compared to the average of -10.34 of the last 4 quarters.

Xenon Pharmaceuticals Inc. (XENE) Historical PE Ratio (quarterly & annually)

How has XENE PE Ratio performed in the past?

The mean historical PE Ratio of Xenon Pharmaceuticals Inc. over the last ten years is -11.05. The current -11.47 PE Ratio has changed 10.28% with respect to the historical average. Over the past ten years (40 quarters), XENE's PE Ratio was at its highest in in the December 2017 quarter at -1.56. The PE Ratio was at its lowest in in the June 2020 quarter at -626.63.

Quarterly (TTM)
Annual

Average

-11.05

Median

-10.60

Minimum

-19.04

Maximum

-1.66

Xenon Pharmaceuticals Inc. (XENE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Xenon Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 130.09%

Maximum Annual PE Ratio = -1.66

Minimum Annual Increase = -134.62%

Minimum Annual PE Ratio = -19.04

Quarterly (TTM)
Annual
YearPE RatioChange
2024-13.03-22.86%
2023-16.89-11.29%
2022-19.0410.20%
2021-17.28-6.21%
2020-18.42125.34%
2019-8.18130.09%
2018-3.55114.35%
2017-1.66-68.05%
2016-5.19-28.84%
2015-7.29-134.62%

Xenon Pharmaceuticals Inc. (XENE) Average PE Ratio

How has XENE PE Ratio performed in the past?

The current PE Ratio of Xenon Pharmaceuticals Inc. (XENE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-16.32

5-year avg

-16.93

10-year avg

-11.05

Xenon Pharmaceuticals Inc. (XENE) PE Ratio vs. Peers

How is XENE’s PE Ratio compared to its peers?

Xenon Pharmaceuticals Inc.’s PE Ratio is greater than Centessa Pharmaceuticals plc (-17.15), greater than Apogee Therapeutics, Inc. (-17.49), greater than ASCENTAGE PHARMA GROUP INTERNATIONAL (-63.93), less than Ultragenyx Pharmaceutical Inc. (-6.29), greater than Celcuity Inc. (-29.14), less than Zai Lab Limited (-10.30), greater than CG Oncology, Inc. Common stock (-31.87), greater than Scholar Rock Holding Corporation (-14.54), greater than Travere Therapeutics, Inc. (-35.61), less than Legend Biotech Corporation (-7.86),

Build a custom stock screener for Xenon Pharmaceuticals Inc. (XENE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xenon Pharmaceuticals Inc. (XENE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xenon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Xenon Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Xenon Pharmaceuticals Inc. (XENE)?

What is the highest PE Ratio for Xenon Pharmaceuticals Inc. (XENE)?

What is the 3-year average PE Ratio for Xenon Pharmaceuticals Inc. (XENE)?

What is the 5-year average PE Ratio for Xenon Pharmaceuticals Inc. (XENE)?

How does the current PE Ratio for Xenon Pharmaceuticals Inc. (XENE) compare to its historical average?